Literature DB >> 2787034

Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.

R S Hellman1, R S Tikofsky, B D Collier, R G Hoffmann, D W Palmer, S L Glatt, P G Antuono, A T Isitman, R A Papke.   

Abstract

To enable a more quantitative diagnosis of senile dementia of the Alzheimer type (SDAT), the authors developed and tested a semiautomated method to define regions of interest (ROIs) to be used in quantitating results from single photon emission computed tomography (SPECT) of regional cerebral blood flow performed with N-isopropyl iodine-123-iodoamphetamine. SPECT/IMP imaging was performed in ten patients with probable SDAT and seven healthy subjects. Multiple ROIs were manually and semiautomatically generated, and uptake was quantitated for each ROI. Mean cortical activity was estimated as the average of the mean activity in 24 semiautomatically generated ROIs; mean cerebellar activity was determined from the mean activity in separate ROIs. A ratio of parietal to cerebellar activity less than 0.60 and a ratio of parietal to mean cortical activity less than 0.90 allowed correct categorization of nine of ten and eight of ten patients, respectively, with SDAT and all control subjects. The degree of diminished mental status observed in patients with SDAT correlated with both global and regional changes in IMP uptake.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787034     DOI: 10.1148/radiology.172.1.2787034

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

2.  Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study.

Authors:  A M Catafau; F J Lomeña; J Pavia; E Parellada; M Bernardo; J Setoain; E Tolosa
Journal:  Eur J Nucl Med       Date:  1996-10

3.  Effects of non-linear flow and spatial orientation on technetium-99m hexamethylpropylene amine oxime single-photon emission tomography.

Authors:  S J Stapleton; C B Caldwell; L E Ehrlich; C L Leonhardt; S E Black; M J Yaffe
Journal:  Eur J Nucl Med       Date:  1995-09

4.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease.

Authors:  K A Jobst; A D Smith; C S Barker; A Wear; E M King; A Smith; P A Anslow; A J Molyneux; B J Shepstone; N Soper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.

Authors:  H Karbe; A Kertesz; J Davis; B J Kemp; F S Prato; R L Nicholson
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

6.  Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia.

Authors:  P R Talbot; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  Eur J Nucl Med       Date:  1994-06

Review 7.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

8.  Three-dimensional surface display of brain perfusion with 123I-IMP in Parkinson's disease.

Authors:  H Tachibana; K Kawabata; Y Tomino; M Sugita; M Fukuchi
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

9.  Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography.

Authors:  W A Van Gool; G J Walstra; S Teunisse; F M Van der Zant; H C Weinstein; E A Van Royen
Journal:  J Neurol       Date:  1995-06       Impact factor: 4.849

10.  Effective diagnosis of Alzheimer's disease by means of large margin-based methodology.

Authors:  Rosa Chaves; Javier Ramírez; Juan M Górriz; Ignacio A Illán; Manuel Gómez-Río; Cristobal Carnero
Journal:  BMC Med Inform Decis Mak       Date:  2012-07-31       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.